DuPont de Nemours, Inc. (DD)
| Market Cap | 19.42B +22.8% |
| Revenue (ttm) | 7.06B +95.5% |
| Net Income | 301.00M |
| EPS | 2.19 |
| Shares Out | 132.53M |
| PE Ratio | 66.84 |
| Forward PE | 18.29 |
| Dividend | $2.40 (1.64%) |
| Ex-Dividend Date | Nov 30, 2026 |
| Volume | 975,767 |
| Open | 144.98 |
| Previous Close | 144.93 |
| Day's Range | 144.05 - 147.76 |
| 52-Week Range | 111.15 - 157.98 |
| Beta | 1.10 |
| Analysts | Buy |
| Price Target | 172.24 (+17.55%) |
| Earnings Date | Nov 3, 2026 |
About DD
DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through two segments, Healthcare & Water Technologies and Diversified Industrials. The company offers specialty components for medical devices, packaging and garments, and protective suits under the brand TYVEK; provides water filtration and separation solutions, including elements, modules, and systems serving primarily industrial wastewater and energy markets,... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 18 analysts, the average rating for DD stock is "Buy." The 12-month stock price target is $172.24, which is an increase of 17.55% from the latest price.
News
DuPont price target raised to $173 from $160 at RBC Capital
RBC Capital raised the firm’s price target on DuPont (DD) to $173 from $160 and keeps an Outperform rating on the shares. The company’s Q3 earnings beat was driven by…
DuPont price target raised to $170 from $166 at Wells Fargo
Wells Fargo raised the firm’s price target on DuPont (DD) to $170 from $166 and keeps an Overweight rating on the shares. The firm notes the company continues to deliver…
DuPont price target raised to $182 from $172 at UBS
UBS analyst Joshua Spector raised the firm’s price target on DuPont (DD) to $182 from $172 and keeps a Buy rating on the shares.
DuPont price target raised to $168 from $159 at BofA
BofA raised the firm’s price target on DuPont (DD) to $168 from $159 and keeps a Neutral rating on the shares. The multiple could ultimately be capped below management’s target…
DuPont price target raised to $165 from $156 at Mizuho
Mizuho raised the firm’s price target on DuPont (DD) to $165 from $156 and keeps an Outperform rating on the shares.
DuPont price target raised to $169 from $153 at Goldman Sachs
Goldman Sachs analyst Joe Ritchie raised the firm’s price target on DuPont (DD) to $169 from $153 and keeps a Neutral rating on the shares.
DuPont price target raised to $176 from $162 at Citi
Citi analyst Patrick Cunningham raised the firm’s price target on DuPont (DD) to $176 from $162 and keeps a Buy rating on the shares.
DuPont price target raised to $176 from $156 at Barclays
Barclays analyst Aleksey Yefremov raised the firm’s price target on DuPont (DD) to $176 from $156 and keeps an Overweight rating on the shares following the Q3 report. The firm…
DuPont de Nemours Earnings Call Transcript: Q3 2026
Q3 organic sales grew 5%, EBITDA margin expanded 90 bps, and adjusted EPS rose 31%. FY26 guidance increased again, with productivity, healthcare, aerospace, and EV battery demand supporting results.
DuPont de Nemours Slides: Q3 2026
DuPont de Nemours has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on November 3, 2026.
DuPont de Nemours Earnings release: Q3 2026
DuPont de Nemours released its Q3 2026 earnings on November 3, 2026, summarizing the period's financial results.
DuPont de Nemours Quarterly report: Q3 2026
DuPont de Nemours has published its Q3 2026 quarterly earnings report on November 3, 2026.
DuPont Swings to a Profit and Lifts Outlook
DuPont swung to a third-quarter profit of $123 million, or 91 cents a share, from a loss of $123 million, or 88 cents a share, a year earlier.
DuPont reports Q3 adjusted EPS $2.09, consensus $1.88
Reports Q3 revenue $1.87B, consensus $1.84B. “We delivered another quarter of consistent, high-quality performance, once again exceeding our financial guidance,” said Lori Koch, DuPont (DD) Chief Exec...
DuPont raises full-year profit forecasts on strong healthcare, aerospace demand
DuPont lifted its full-year profit forecasts on Tuesday and projected current-quarter earnings above Wall Street estimates after a third-quarter performance boost from strong healthcare, aerospace and...
DuPont Reports Third Quarter 2026 Results
Exceeds Third Quarter 2026 Guidance Raises Full Year 2026 Guidance Third Quarter 2026 Highlights Net Sales of $1.9 billion increased 4%; organic sales increased 5% versus year-ago period GAAP Income f...
DuPont Net-Zero Climate Targets Validated by Science Based Targets initiative
SBTi validation recognizes DuPont's continued climate progress, with new 2035 emissions-reduction targets and a 2050 net-zero target WILMINGTON, Del., Oct. 29, 2026 /PRNewswire/ -- DuPont (NYSE: DD) t...
duPont REGISTRY Group to Showcase Lineup of Supercars at Concours at Wynn Las Vegas
MIAMI--(BUSINESS WIRE)--duPont REGISTRY Group to Showcase Lineup of Supercars at Concours at Wynn Las Vegas.
DuPont Launches AmberChrom™ SIL Silica Gel for Chromatography to Advance Manufacturing of GLP-1 and Other Peptide Therapeutics
New silica-based chromatography media helps biopharmaceutical manufacturers achieve demanding purity targets while supporting integrated purification workflows from crude purification through final po...
DuPont price target lowered to $160 from $176 at RBC Capital
RBC Capital analyst Arun Viswanathan lowered the firm’s price target on DuPont (DD) to $160 from $176 and keeps an Outperform rating on the shares as part of a broader…
DuPont Announces Regular Quarterly Dividend on Common Stock
WILMINGTON, Del., Oct. 13, 2026 /PRNewswire/ -- DuPont (NYSE: DD) today announced that its Board of Directors has declared a quarterly dividend of sixty cents ($0.60) per share on the outstanding Comm...
DuPont initiated with an Overweight at Barclays
Barclays analyst Aleksey Yefremov initiated coverage of DuPont (DD) with an Overweight rating and $156 price target
DuPont downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Chigusa Katoku downgraded DuPont (DD) to Neutral from Overweight with a price target of $145, down from $172. JPMorgan also removed DuPont from its Analyst Focus List. The…
DuPont price target lowered to $162 from $170 at Citi
Citi analyst Patrick Cunningham lowered the firm’s price target on DuPont (DD) to $162 from $170 and keeps a Buy rating on the shares. The firm adjusted targets in the…
DuPont Schedules Third Quarter 2026 Earnings Conference Call
WILMINGTON, Del., Oct. 6, 2026 /PRNewswire/ -- DuPont (NYSE: DD) will release its third quarter 2026 financial results at 6:00 a.m.